Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Director departure
ChemoCentryx, Inc. (CCXI) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/05/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
03/01/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "ChemoCentryx Reports Third Quarter 2020 Financial Results and Recent Highlights"
08/10/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
03/10/2020 8-K Quarterly results
11/04/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 of the Securities Exchange Act of 1934 Date of Report : November 4, 2019 ChemoCentryx, Inc. Delaware 001-35420 94-3254365 850 Maude Avenue, Mountain View, CA 94043 Registrant's telephone number, including area code: 210-2900",
"ChemoCentryx Reports Third Quarter 2019 Financial Results and Recent Highlights"
08/05/2019 8-K Quarterly results
05/06/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 of the Securities Exchange Act of 1934 Date of Report : May 6, 2019 ChemoCentryx, Inc. Delaware 001-35420 94-3254365 850 Maude Avenue, Mountain View, CA 94043 Registrant's telephone number, including area code: 210-2900",
"ChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights"
03/11/2019 8-K Quarterly results
Docs: "ChemoCentryx Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights"
11/08/2018 8-K Quarterly results
Docs: "FORM 8-K",
"ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights"
08/09/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 of the Securities Exchange Act of 1934 Date of Report : August 9, 2018 ChemoCentryx, Inc. Delaware 001-35420 94-3254365 850 Maude Avenue, Mountain View, CA 94043 Registrant's telephone number, including area code: 210-2900",
"ChemoCentryx Reports Second Quarter 2018 Financial Results and Recent Highlights"
05/09/2018 8-K Quarterly results
Docs: "FORM 8-K",
"ChemoCentryx Reports First Quarter 2018 Financial Results and Recent Highlights"
03/09/2018 8-K Quarterly results
Docs: "FORM 8-K",
"ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights"
11/07/2017 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 of the Securities Exchange Act of 1934 Date of Report : November 7, 2017 CHEMOCENTRYX, INC. Delaware 001-35420 94-3254365 850 Maude Avenue, Mountain View, CA 94043 Registrant's telephone number, including area code: 210-2900",
"ChemoCentryx Reports Third Quarter 2017 Financial Results and Recent Highlights"
08/08/2017 8-K Quarterly results
05/10/2017 8-K Form 8-K - Current report
03/14/2017 8-K Form 8-K - Current report
11/07/2016 8-K Quarterly results
Docs: "ChemoCentryx Reports Third Quarter 2016 Financial Results and Provides Corporate Update"
05/10/2016 8-K Form 8-K - Current report
03/14/2016 8-K Form 8-K - Current report
11/09/2015 8-K Quarterly results
Docs: "ChemoCentryx Reports Third Quarter 2015 Financial Results and Provides Corporate Update"
08/06/2015 8-K Quarterly results
Docs: "ChemoCentryx Reports Second Quarter 2015 Financial Results and Provides Corporate Update"
05/06/2015 8-K Quarterly results
Docs: "ChemoCentryx Reports First Quarter 2015 Financial Results and Provides Corporate Update"
03/12/2015 8-K Quarterly results
Docs: "ChemoCentryx Reports Fourth Quarter 2014 Financial Results and Provides Corporate Update"
11/05/2014 8-K Quarterly results
Docs: "ChemoCentryx Reports Third Quarter 2014 Financial Results and Provides Corporate Update"
08/05/2014 8-K Quarterly results
Docs: "ChemoCentryx Announces Financial Results for the Second Quarter Ended June 30, 2014 Conference Call Scheduled Today at 5:00 pm ET / 2:00 pm PT"
05/08/2014 8-K Quarterly results
Docs: "ChemoCentryx Announces Financial Results for the First Quarter Ended March 31, 2014 Conference Call Scheduled Today at 5:00 pm ET / 2:00 pm PT"
03/13/2014 8-K Quarterly results
Docs: "ChemoCentryx Announces Financial Results for the Quarter and Year Ended December 31, 2013"
11/07/2013 8-K Form 8-K - Current report
08/12/2013 8-K Form 8-K - Current report
05/14/2013 8-K Quarterly results
Docs: "ChemoCentryx Announces Financial Results for the Quarter Ended March 31, 2013"
03/14/2013 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy